Cargando…

Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System

BACKGROUND AND AIMS: Intrahepatic cholangiocarcinoma (iCCA) with liver metastases is perceived to have a poor prognosis, but the American Joint Committee on Cancer (AJCC) classifies them as early stage in the absence of lymph nodes or extrahepatic spread. APPROACH AND RESULTS: Patients with iCCA fro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lamarca, Angela, Santos‐Laso, Alvaro, Utpatel, Kirsten, La Casta, Adelaida, Stock, Simone, Forner, Alejandro, Adeva, Jorge, Folseraas, Trine, Fabris, Luca, Macias, Rocio I.R., Krawczyk, Marcin, Krawczyk, Marek, Cardinale, Vincenzo, Braconi, Chiara, Alvaro, Domenico, Evert, Matthias, Banales, Jesus M., Valle, Juan W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252018/ https://www.ncbi.nlm.nih.gov/pubmed/33073396 http://dx.doi.org/10.1002/hep.31598

Ejemplares similares

Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Patients with Resected Perihilar Cholangiocarcinoma: The ENSCCA Registry
por: Nooijen, Lynn E., et al.
Publicado: (2022)

Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis
por: Banales, Jesus M., et al.
Publicado: (2019)

Setup of multidisciplinary team discussions for patients with cholangiocarcinoma: current practice and recommendations from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
por: Casadio, M., et al.
Publicado: (2022)

Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma
por: Lapitz, Ainhoa, et al.
Publicado: (2023)

Lacking Immunotherapy Biomarkers for Biliary Tract Cancer: A Comprehensive Systematic Literature Review and Meta-Analysis
por: Frega, Giorgio, et al.
Publicado: (2023)

Inhibition of MELK Protooncogene as an Innovative Treatment for Intrahepatic Cholangiocarcinoma
por: Cigliano, Antonio, et al.
Publicado: (2019)

Cholangiocarcinoma 2020: the next horizon in mechanisms and management
por: Banales, Jesus M., et al.
Publicado: (2020)

Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease Diagnosis
por: Lapitz, Ainhoa, et al.
Publicado: (2020)

Locoregional Treatment in Intrahepatic Cholangiocarcinoma: Which Treatment for Which Patient?
por: Bourien, Héloïse, et al.
Publicado: (2023)

A Novel Serum Metabolomic Profile for the Differential Diagnosis of Distal Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma
por: Macias, Rocio I.R., et al.
Publicado: (2020)

Intrahepatic cholangiocarcinoma hidden within cancer of unknown primary
por: Conway, Alicia-Marie, et al.
Publicado: (2022)

Heterogeneity of Cholangiocarcinoma Immune Biology
por: Vita, Francesca, et al.
Publicado: (2023)

The promise of precision medicine: how biomarkers are shaping the future of cholangiocarcinoma treatment
por: Macias, Rocio I. R., et al.
Publicado: (2023)

Periostin and mesothelin: Potential predictors of malignant progression in intrahepatic cholangiocarcinoma
por: Mandrekar, Pranoti, et al.
Publicado: (2018)

The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease
por: Cigliano, Antonio, et al.
Publicado: (2022)

Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis – The promise of DNA methylation and molecular biomarkers
por: Vedeld, Hege Marie, et al.
Publicado: (2020)

Matrisome analysis of intrahepatic cholangiocarcinoma unveils a peculiar cancer-associated extracellular matrix structure
por: Carpino, Guido, et al.
Publicado: (2019)

Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease
por: Cigliano, Antonio, et al.
Publicado: (2023)

Intrahepatic Sarcomatoid Cholangiocarcinoma
por: Malhotra, Shalini, et al.
Publicado: (2010)

Asbestos and Intrahepatic Cholangiocarcinoma
por: Brandi, Giovanni, et al.
Publicado: (2020)

Management of Intrahepatic Cholangiocarcinoma
por: Kodali, Sudha, et al.
Publicado: (2021)

Current and novel therapeutic opportunities for systemic therapy in biliary cancer
por: Marin, José J. G., et al.
Publicado: (2020)

Two Varieties of Intrahepatic Cholangiocarcinoma
por: Nagorney, David M.
Publicado: (1994)

Intrahepatic Cholangiocarcinoma with Sarcomatous Changes
por: Inoue, Yoshiyuki, et al.
Publicado: (2012)

Serum Markers of Intrahepatic Cholangiocarcinoma
por: Malaguarnera, Giulia, et al.
Publicado: (2013)

Intrahepatic cholangiocarcinoma: current perspectives
por: Buettner, Stefan, et al.
Publicado: (2017)

Intratumoral heterogeneity of intrahepatic cholangiocarcinoma
por: Walter, Dirk, et al.
Publicado: (2017)

Molecular heterogeneity in intrahepatic cholangiocarcinoma
por: Ahn, Keun Soo, et al.
Publicado: (2020)

Recurrent Intrahepatic Cholangiocarcinoma – Review
por: Bekki, Yuki, et al.
Publicado: (2021)

Stereotactic radiotherapy for intrahepatic cholangiocarcinoma
por: Borakati, Aditya, et al.
Publicado: (2022)

Surgical Aspects of Intrahepatic Cholangiocarcinoma
por: Kupietzky, Amram, et al.
Publicado: (2022)

Locoregional Therapy for Intrahepatic Cholangiocarcinoma
por: Owen, Mackenzie, et al.
Publicado: (2023)

TGFβ-induced circLTBP2 predicts a poor prognosis in intrahepatic cholangiocarcinoma and mediates gemcitabine resistance by sponging miR-338-3p
por: Louis, Corentin, et al.
Publicado: (2023)

Intrahepatic cholangiocarcinoma arising in Caroli's disease
por: Jang, Min Hye, et al.
Publicado: (2014)

The role of microRNAs in intrahepatic cholangiocarcinoma
por: Li, Zheng, et al.
Publicado: (2016)

Prostatic metastasis from intrahepatic cholangiocarcinoma
por: Tosev, Georgi, et al.
Publicado: (2018)

Systemic and Adjuvant Therapies for Intrahepatic Cholangiocarcinoma
por: Chun, Yun Shin, et al.
Publicado: (2017)

Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Massarweh, Nader N., et al.
Publicado: (2017)

The construction of intrahepatic cholangiocarcinoma model in zebrafish
por: Wang, Jing, et al.
Publicado: (2017)

Neoadjuvant treatment strategies for intrahepatic cholangiocarcinoma
por: Akateh, Clifford, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_itu79fio4h3o1257tjpe97k6mh